Download presentation
Presentation is loading. Please wait.
Published byPatrik Lindqvist Modified over 5 years ago
1
Study Design ADA, adalimumab; DL, drug levels; FCP, faecal calprotectin; pCCR, patient-reported continuous clinical response; PRO, patient-reported outcomes. Study Design ADA, adalimumab; DL, drug levels; FCP, faecal calprotectin; pCCR, patient-reported continuous clinical response; PRO, patient-reported outcomes. Juliette Sheridan et al. BMJ Open Gastroenterol 2018;5:e000174 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.